biospecimen

  • Image

    Columbia University

    The mission of the Irving Institute for Clinical and Translational Research is to advance discoveries, knowledge, and innovation to improve human health across the lifespan for diverse populations in upper Manhattan and around the world. By mobilizing and connecting Columbia University’s researchers, we aim to create a seamless integration of community and academic partnerships. Our commitment to train a multi-faceted workforce, provide vital resources to researchers, and improve the efficiency of research processes, promotes the collaborative team science framework needed to translate research discoveries into effective interventions that address current and future health concerns.

    We provide over 70 different services and programs focused on education and training, seed funding, bioinformatics, biostatistics, clinical research, lifespan research and special populations, regulatory knowledge and bioethics, an off-site community facility and health informatics websites.
  • CD2H-teal
    -
    Center for Data to Health
    The CD2H Biobank Incubator project being developed by the Next Generation Data Sharing Core will demonstrate the BioCatalyst platform on Weds June 23, 2021 at 10amPT/1pm ET. BioCatalyst is a first-of-its-kind search engine/application that allows biobanks to connect both clinical attributes and biological/molecular data to existing biospecimens in a central, easy-to-use virtual ecosystem. As of
  • The National Institutes of Health COVID-19 NeuroDatabank and NeuroBioBank, funded by the National Institute of Neurological Disorders and Stroke, has been initiated at NYU Langone Health. We will create and maintain a national resource documenting and studying neurological complications of coronavirus disease (COVID-19), the illness caused by infection with the SARS-CoV-2 novel coronavirus

  • Thermo Fisher Scientific
    -
    Center for Data to Health

    Researchers require innovative solutions to ensure that their biobanking projects are a success. From initial sample collection to storage and use in downstream applications, precious biospecimens should be handled with care. Precision medicine research in particular relies on sophisticated biobanking systems to maintain sample integrity and streamline workflows. In this webinar, brought to you by

  • Accelerating research has become more important than ever in the face of a global pandemic. By creating a model that meets the need for speed, the University of Minnesota can hasten the development of therapeutics—not just for one candidate, but for COVID-19 treatments being developed across UMN.

  • In case you were unable to attend the July 15, 2020 webinar, you can now watch the recording! Opening remarks by CD2H leader Chris Chute. Guest speakers included Danielle Mowery, Marylyn Ritchie & Christian Stoeckert of the University of Pennsylvania and Rohit Gupta of the University of California, San Francisco for a discussion of biospecimens and their phenotypes for data sharing.

  • CD2H-teal
    -
    Center for Data to Health

    Come join a webinar to discuss the sharing of data for biospecimens and their phenotypes. Chris Chute, MD, DrPH & Melissa Haendel, PhD of CD2H will present: • Perspectives from CD2H for cross-CTSA collaboration • Emphasis on sharing tools and data Next generation tools and best practices will be presented by guest speakers: • UPenn: Danielle Mowery, PhD; Marylyn Ritchie, PhD, and Christian

  • Introduction: Informed consent for research biospecimen donations is traditionally obtained through a face-to-face interaction with research staff and by signing an Institutional Review Board (IRB)-approved printed form. Electronic signatures (eSign) are routinely used in the electronic medical record (EMR) for the consenting of clinical services after patients review printed documentation. Our